MDWD
Mediwound Ltd
NASDAQ: MDWD · HEALTHCARE · BIOTECHNOLOGY
$16.25
-1.87% today
Updated 2026-04-29
Market cap
$208.85M
P/E ratio
—
P/S ratio
12.31x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$15 – $23
Volume
0.1M
Mediwound Ltd (MDWD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-140.80%
Operating margin
-417.80%
ROE
-63.90%
ROA
-19.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-6.17M | — | — | — |
| 2012 | — | $10.94M | — | — | — |
| 2013 | $0.00 | $-15.35M | — | — | — |
| 2014 | $259000.00 | $-18.88M | -994.21% | -8,272.97% | -7,287.64% |
| 2015 | $601000.00 | $-22.09M | -333.44% | -3,531.95% | -3,675.21% |
| 2016 | $1.56M | $-18.89M | -45.70% | -1,293.65% | -1,212.13% |
| 2017 | $2.50M | $-22.15M | 32.37% | -548.36% | -887.38% |
| 2018 | $3.40M | $-1.06M | 35.58% | -315.97% | -31.08% |
| 2019 | $31.79M | $4.96M | 60.72% | 17.82% | 15.59% |
| 2020 | $21.76M | $-9.20M | 32.21% | -40.62% | -42.26% |
| 2021 | $23.76M | $-13.55M | 34.24% | -47.22% | -57.03% |
| 2022 | $26.50M | $-19.60M | 46.50% | -28.91% | -73.97% |
| 2023 | $18.69M | $-6.72M | 15.77% | -82.96% | -35.94% |
| 2024 | $20.22M | $-30.22M | 8.81% | -95.85% | -149.46% |
| 2025 | $16.96M | $-23.88M | 12.59% | -149.06% | -140.80% |